Louisiana Funds — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Calosyn Pharmacalosynpharma.comDec 2022
BiotechShreveport, US
Joseph Lovett(Director)Richard Babb(Treasurer)David Waddell(Director)Ross P. Barrett(Secretary)William R. Grimes(President and Chief Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.